C-Reactive Protein Testing Market Growth Report 2024-2033

The new report published by The Business Research Company, titled ""C-Reactive Protein Testing Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the c-reactive protein testing market size has grown steadily in recent years. It will grow from $3.43 billion in 2023 to $3.55 billion in 2024 at a compound annual growth rate (CAGR) of 3.6%. The c-reactive protein testing market size is expected to see steady growth in the next few years. It will grow to $4.16 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp

Cardiovascular Disease Epidemic And The Vital Role Of C-Reactive Protein Testing In Market Growth
The increase in cases of cardiovascular diseases (CVD) are expected to propel the growth of the c-reactive protein testing market. Cardiovascular diseases refer to heart conditions such as diseased vessels, structural problems, and blood clots. The exact cause of CVD is uncertain, but numerous factors can increase the risk of developing it. One such factor is the behavioral risk caused due to unbalanced eating, lack of physical activity, smoking, and alcohol use, which results in an accumulation of fatty deposits inside the arteries (atherosclerosis), resulting in an increased risk of blood clots. These behavioral risks result in elevated blood pressure, glucose, blood lipids, weight gain, and obesity. The increasing cases of cardiovascular diseases invites the need for c-reactive protein testing to diagnose or predict the chance of having cardiovascular problems at least as well as cholesterol levels. For instance, according to the key facts published in June 2021 by the WHO (World Health Organization), cardiovascular diseases are the leading cause of death worldwide. Around 17.9 million die every year due to CVD, accounting for 32% of all global deaths. Therefore, the increasing cases of cardiovascular diseases will drive the c-reactive protein testing market growth.

Technological Advancements Transforming The C-Reactive Protein Testing Market
Technological advancement in measuring devices is a key trend in the c-reactive protein testing market. Major companies operating in the c-reactive protein testing market are focused on providing technologically advanced solutions to strengthen their market position. These companies are implementing next-generation c-reactive testing technologies into their testing methods and advanced solutions that provide benefits such as maximum output and multiple usages. For instance, in February 2022, Aidian, a Finnish-based diagnostic tests, and test solutions company, released the QuikRead go wrCRP & wrCRP+Hb kits. The kit consistently produces two results, a wide range of CRP and Hb, from a single sample with one analysis. The wide-range CRP test permits CRP readings to assess conditions such as neonatal sepsis, predict disease severity in COPD (chronic obstructive pulmonary disease), and assist in cardiovascular risk assessment.

The c-reactive protein testing market covered in this report is segmented -

1) By Assay Type: Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assays
2) By Application: Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, Cancer, Other Applications
3) By End Use: Clinics, Hospitals, Diagnostic Laboratories

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=6719&type=discount

Major companies operating in the c-reactive protein testing market include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Abaxis Inc., Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., ProciseDx LLC, Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Johnson & Johnson Clinical Diagnostics, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Corgenix Medical Corporation, Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, Nova Biomedical Corporation

Contents of the report:
1. Executive Summary
2. C-Reactive Protein Testing Market Report Structure
3. C-Reactive Protein Testing Market Trends And Strategies
4. C-Reactive Protein Testing Market - Macro Economic Scenario
5. C-Reactive Protein Testing Market Size And Growth
…..
27. C-Reactive Protein Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.